| Literature DB >> 25780634 |
Ah-Ram Lee1, Je-Min Yim1, Won-Il Kim1.
Abstract
OBJECTIVES: The aim of this study was to investigate the safety and the efficacy of Korean herbal, western and combination medicine use in patients with abnormal liver function tests.Entities:
Keywords: drug induced; herbal medicine; liver function tests; liver injury
Year: 2012 PMID: 25780634 PMCID: PMC4331929 DOI: 10.3831/KPI.2012.15.1.034
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
General characteristics of all cases
| N | Herbal | Western | Combined | |||
|---|---|---|---|---|---|---|
| Sex | Male | 45 (50%) | 12 (40%) | 18 (60%) | 15 (50%) | 0.325 |
| Female | 45 (50%) | 18 (60%) | 12 (40%) | 15 (50%) | ||
| Age (mean ± SD* (yr)) | 57.67±13.75 | 57.97±13.61 | 63.53±11.44 | 51.67±13.79 | 0.003† | |
| Duration of medication (mean ± SD (day)) | 14.67±10.68 | 16.00±11.80 | 14.80±11.08 | 13.20±9.17 | 0.600 | |
| Impression | Cerebral infarction | 44 (49%) | 16 (53%) | 19 (63%) | 9 (30%) | 0.018‡ |
| Intracranial hemorrhage | 16 (18%) | 7 (23%) | 4 (13%) | 5 (17%) | ||
| Bell's palsy | 13 (14%) | 4 (13%) | 0 (0%) | 9 (30%) | ||
| Headache, dizziness | 4 (4%) | 0 (0%) | 1 (3%) | 3 (10%) | ||
| Others | 13 (14%) | 3 (10%) | 6 (20%) | 4 (13%) | ||
* Standard deviation
† Significant different (p〈 0.01).
‡ Significant different (p〈 0.05).
Change of LFT in herbal medication
| Herbal medication | before | after | |
|---|---|---|---|
| Aspartic aminotransferase (U/L) | 49.77±24.86 | 29.80±11.05 | 0.000* |
| Alanine aminotransferase (U/L) | 56.10±17.53 | 34.50±19.56 | 0.000* |
| Alkaline phosphatase (U/L) | 69.20±19.54 | 74.80±34.08 | 0.164 |
| Total bilirubin (mg/dL) | 0.81±0.55 | 0.76±0.30 | 0.484 |
* Significant different (p〈 0.01).
Change of LFT in western medication
| Western medication | before | after | |
|---|---|---|---|
| AST (U/L) | 65.77±27.43 | 30.80±9.79 | 0.000* |
| ALT (U/L) | 75.47±36.87 | 28.60±14.59 | 0.000* |
| ALP (U/L) | 88.54±34.17 | 79.93±19.72 | 0.100 |
| T-bil (mg/dL) | 0.76±0.72 | 0.66±0.28 | 0.285 |
* Significant different (p〈 0.01).
Change of LFT in combined medication
| Combined medication | before | after | |
|---|---|---|---|
| AST (U/L) | 60.73±35.94 | 37.87±15.46 | 0.001* |
| ALT (U/L) | 89.37±12.97 | 34.20±12.97 | 0.000* |
| ALP (U/L) | 76.97±24.26 | 65.70±20.15 | 0.000* |
| T-bil (mg/dL) | 0.75±0.25 | 0.67±0.20 | 0.023† |
* Significant different (p〈 0.01).
† Significant different (p〈 0.05).
Comparison of LFT Changes between herbal medication and western medication
| Mean change | Herbal medication | Western medication | |
|---|---|---|---|
| AST (U/L) | 19.97±22.81 | 34.97±30.79 | 0.036† |
| ALT (U/L) | 21.60±23.52 | 46.87±37.33 | 0.003* |
| ALP (U/L) | -5.60±21.49 | 8.60±27.71 | 0.031† |
| T-bil (mg/dL) | 0.05±0.41 | 0.10±0.50 | 0.695 |
* Significant different (p〈 0.01).
† Significant different (p〈 0.05).
Comparison of LFT changes between herbal medication and combined medication
| Mean change | Herbal medication | Combined medication | |
|---|---|---|---|
| AST (U/L) | 19.97±22.81 | 22.87±33.84 | 0.699 |
| ALT (U/L) | 21.60±23.53 | 55.17±36.97 | 0.000* |
| ALP (U/L) | -5.60±21.49 | 11.27±12.63 | 0.001* |
| T-bil (mg/dL) | 0.05±0.41 | 0.08±0.18 | 0.747 |
* Significant different (p〈 0.01).
Comparison of LFT changes between western medication and combined medication
| Mean change | Western medication | Combined medication | |
|---|---|---|---|
| AST (U/L) | 34.97±30.79 | 22.87±33.84 | 0.153 |
| ALT (U/L) | 46.87±37.33 | 55.17±36.97 | 0.390 |
| ALP (U/L) | 8.60±27.71 | 11.27±12.63 | 0.633 |
| T-bil (mg/dL) | 0.10±0.50 | 0.08±0.18 | 0.838 |
Comparison of LFT changes
| Mean change | Herbal medication | Western medication | Combined medication | |
|---|---|---|---|---|
| AST (U/L) | 19.97±22.81 | 34.97±30.79 | 22.87±33.84 | 0.119 |
| ALT (U/L) | 21.60±23.53 | 46.87±37.33 | 55.17±36.97 | 0.001* |
| ALP (U/L) | -5.60±21.49 | 8.60±27.71 | 11.27±12.63 | 0.007* |
| T-bil (mg/dL) | 0.05±0.41 | 0.10±0.50 | 0.08±0.18 | 0.897 |
* Significant different (p〈 0.01).